Sign in
Taking peopleNo phase

Crainio Non-invasive ICP Monitor for TBI

Key facts

Who runs it
Crainio Ltda
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
54 people, planned
Started
15 May 2025
Expected to end
15 Dec 2026
Type of study
Interventional
Treatments tested
  • Crainio
Record updated
18 March 2026

Who can take part

Age
16 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Clinical diagnosis of traumatic brain injury
  • Adults (aged between 16 and 99, male and female)
  • TBI patients admitted to the Royal London Hospital
  • Patients having invasive ICP monitoring as part of their normal medical treatment

Who cannot take part

  • Forehead skin is not intact
  • Decompressive craniectomy patients
  • Open external ventricular drainage (EVD) treatment
  • Patients who will unlikely survive the following twelve hours

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 16 and 99 years old?

This trial is currently available in United Kingdom.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The clinical investigation aims to advance the Crainio device, designed for non-invasive intracranial pressure (ICP) monitoring. This feasibility study involves 54 participants over a 12-month period and seeks to collect cerebral photoplethysmogram signals alongside concurrent invasive ICP measurements in patients with traumatic brain injury. The primary objective is to establish the diagnostic accuracy of the Crainio device, aiming for at least 90% sensitivity and specificity in detecting raised ICP (above 20 mmHg). Secondary objectives include evaluating patient-related factors such as skin tone, skull thickness, and skull density, as well as the tolerability and acceptance of the device by both patients and healthcare professionals.

The group in the trial

  • CrainioTreatment being tested

    Acquisition of cerebral PPG signals from Crainio's probe stuck to the patient's forehead, alongside concurrent invasive ICP measurements in patients with traumatic brain injury

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Crainio Non-invasive Intracranial Pressure Monitor for Traumatic Brain Injury: Product Development
Criteria questions
Built from NCT06453733, who can take part
Record updated
18 March 2026